StockNews.com Begins Coverage on vTv Therapeutics (NASDAQ:VTVT)
StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Free Report) in a note issued to investors on Wednesday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, HC Wainwright initiated coverage on vTv Therapeutics in a research note on Wednesday, April 9th. They set a “buy” rating and a […]
